Aug 2026· American Journal of Medical Genetics. Part A· 0 citations· 22 references
Medicine
TL;DR
This case represents the second confirmed adult-onset CTC1-related disorder and the longest survival to date and suggests that subcutaneous calcifications and progressive renal and multi-organ disease may represent later-onset manifestations of the condition.
Abstract
Biallelic pathogenic variants in the CTC1 gene are associated with cerebroretinal microangiopathy with calcifications and cysts (CRMCCs), also known as Coats plus syndrome (CPS; OMIM #612199). This rare multisystem condition is characterized by early childhood onset of intracranial calcifications, leukodystrophy and cysts, along with retinal telangiectasia and exudates (Coats disease). We report a woman referred to genetics with complex multisystem clinical manifestations beginning in her 30s and progressing over two decades. In keeping with classical features of the condition, she presented a complex medical history of pathological bone fractures, gastrointestinal ectasias, and premature aging. In addition, she developed progressive thrombotic microangiopathy-associated kidney disease requiring transplantation, suspected liver cirrhosis, and subcutaneous dystrophic calcifications. Exome sequencing identified compound heterozygous likely pathogenic variants in CTC1, consisting of a previously reported missense variant and a novel truncating variant confirmed in trans. Despite clinical features suggestive of premature aging, telomere length analysis demonstrated low-normal values for age, supporting emerging evidence that telomere shortening is not a consistent feature of CTC1-related disorders. This case represents the second confirmed adult-onset CTC1-related disorder and the longest survival to date. The findings suggest that subcutaneous calcifications and progressive renal and multi-organ disease may represent later-onset manifestations of the condition. TMA may be a pathologic feature of the multi-system impacts of this rare disease in adults.
Findings support a dose-dependent SLC20A2 disease spectrum and expand the phenotype associated with biallelic loss of function from primary brain calcification toward severe early-onset neurodevelopmental disorder with prominent vascular and leptomeningeal calcification.
Mehmet Burak Mutlu, Abdullah Sezer, Elif Özdemir et al.· Journal of Human Genetics· 0 citations
This case expands the clinical, immunological, and genetic spectrum of TRNT1-related disease and highlights that immune dysregulation may dominate the clinical course and SIFD should be considered in children presenting with sideroblastic anemia associated with recurrent unexplained inflammation, B-cell immunodeficienc...
Francesco Delle Cave, Ivan Taietti, Annalisa Agostini et al.· Frontiers in Immunology· 0 citations
Background: Noonan syndrome is a RASopathy which carries autosomal dominant inheritance and is characterized by variable phenotypic expression involving craniofacial, cardiovascular, skeletal, hematological, and neurodevelopmental abnormalities. Bleeding manifestations are common and may result from platelet dysfunctio...
Tasnim Nusrat, Md. Latiful Bari, S. Selim et al.· Journal of Association of Cl...· 0 citations
AIMS
HNF1B variants cause autosomal dominant tubulointerstitial kidney disease (ADTKD-HNF1B), but the phenotypic spectrum of variants of uncertain significance (VUS) remains incompletely defined. We aimed to characterise the multisystem phenotype associated with the HNF1B p.E105K variant and to examine the mechanism un...
Yun-Ze Wang, Kang-Chun Xu, Peng-Fei Liu et al.· Diabetic Medicine· 0 citations
This family provides a detailed clinical and genetic description of 16p11.2 microduplication carriers with prominent gastrointestinal motility and neuromuscular manifestations, thereby enriching the clinical characterization of this recurrent CNV and supporting substantial intrafamilial phenotypic heterogeneity.
This case raises the possibility of a previously unrecognized vascular manifestation of PRKD1-related CHDED, and highlights the importance of considering rare genetic syndromes in patients with unexplained arteriopathy and congenital heart disease.
P. Kharaziha, K. Junker, Josefine Åhsberg et al.· Genes· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.